For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying ... up at mealtimes with fast-acting insulins.

A trio of Democratic senators want Novo Nordisk to explain why it discontinued one of its long-acting insulin products after it announced a steep price cut on the medication. Sens. Jeanne Shaheen ...

Eli Lilly’s big-selling insulin ... In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the ...

Novo Nordisk is discontinuing one ... Luckily, there are many alternative insulins, both rapid-acting and long-acting. Zilbermint highlights Lantus (insulin glargine) as a good option.

COPENHAGEN, Dec 5 (Reuters) - Danish drug maker Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% from January of ...

The picture shows an ampule of quick-acting ... high insulin prices is unconstitutional. In addition to UHC, the lawsuits filed in New Jersey name drug manufacturers Eli Lilly, Novo Nordisk ...

In 1985, Novo Nordisk pioneered production of recombinant human insulin in yeast. In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by genetic engineering ...

She believed she had bought an Ozempic injection but, instead, it was fast-acting insulin ... in six months Novo Nordisk is the only company in the UK with MHRA-approved products containing ...

Novo Nordisk stock price takes a tumble after the ... Jens Martin Skibsted and Rasmus Bech Hansen argue. The Race For Insulin Pills, So Diabetics Can Put Their Needles Away One of the world's ...